We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ovoca Bio Plc | LSE:OVB | London | Ordinary Share | IE00B4XVDC01 | EUR0.125 (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.60 | 1.50 | 1.70 | 1.60 | 1.53 | 1.60 | 225 | 08:00:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.03M | -4.7M | -0.0576 | -0.28 | 1.31M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/12/2023 08:26 | Another stock desperate for a update. I'm still holding, the size used to be worth a few quid but now it's a few k so I'll leave it and see if the company becomes a cash shell. But dropping on any sale on L2 atm because in this market there is just no support for dead stocks like this with no news no matter how cheap they look and this one is now valued way below cash levels but what is cash burn now. Not worth selling if you hold still imho not worth averaging down either though | dave4545 | |
05/12/2023 02:13 | The Codger,this company lost over £5 million in 2022 financial year so probably has very little funds left now. | bri15 | |
30/11/2023 11:44 | Wtf are you on mate?obviously sniffing something | the codger | |
30/11/2023 09:56 | Will the mugs on the BOD actually admit today that they were duped in the initial Russian trials, or will they keep stringing everyone along for as long as they can? All they need to do is open source the data from the trials and let some stats students loose on it to give a good indication of how likely it is to be genuine... | esmith3 | |
30/11/2023 07:19 | Agm today.company will have to update on strategy going forward. Otherwise the cashshell option is looming. | the codger | |
02/11/2023 08:32 | No brainer at this level. Cash double of market value. | the codger | |
25/10/2023 19:02 | Somebody got a excellent price today 1.2p or less. | dave4545 | |
24/10/2023 20:10 | wow £937k market cap Despite the setback I think this is becoming heavily oversold but in this market most stocks are with no buyers out there and prices getting slashed on just a fraction of sales it would take previously to knock it down. | dave4545 | |
19/9/2023 15:11 | Shameless ramper dave4545 still ramping this one. As soon as there is a spike, he is going to dump | optmist | |
12/9/2023 07:16 | £1.5 mil market cap recent cash £2.2 mil Lots of tax losses, if they give up on the drug it could be a very attractive cash shell. Still they might find a reason for such poor trial results and continue who knows. Just think it's a fraction oversold now | dave4545 | |
05/9/2023 10:43 | More carnage. Hope everyone keeps away from dave4545 advice | optmist | |
01/9/2023 14:55 | I just thought Id post it from the other site. Made me think a bit about it. Cheers for the replies. | recordz | |
01/9/2023 14:39 | Interesting H | dave4545 | |
01/9/2023 14:25 | "a bit strange" Sub 2020 yes...After 2021 no Look at the data in the covid vaccine trials and they got approval...shocking ! So who knows who is telling the truth and who is lying here when it comes to this trial and the old Russian one from 2017 | dave4545 | |
01/9/2023 14:13 | Does anyone find the difference in the trials a bit strange.? From the other place.. Results were very fishy, and if the guys inside are shocked and surprised then there is something wrong somewhere hence why investigating results….could well be some big errors or other but need to wait for analysis. Dr. Daniil Nemenov, SVP for Clinical Development and Operations of Ovoca Bio plc, said: "We are surprised and disappointed that the Study did not have a positive conclusion regarding the superiority of Orenetide versus placebo. The Company now intends to analyse the results from the Study in further detail, including investigating the reasons for potential differences between the Study results and results from previously conducted clinical trials of Orenetide. While we are naturally disappointed with these results, I would like thank all those involved in the Study to date, including the patients who were enrolled, their families, our investigators, staff, and all of the dedicated Ovoca employees." | recordz | |
31/8/2023 18:09 | So market cap has closed exactly the same as cash in RNS end of July. Given there is always a option to turn into a shell and move in a new direction I feel I might as well hold especially as current stake is only worth less than £2k. Remember when ITS collapsed then turned into a shell and 25 bagged from their low. Lets see what Ovb decide to do | dave4545 | |
31/8/2023 16:39 | Mcrudden20 Dec '19 - 15:27 - 38 of 652 0 0 0 Solid company very surprised at those sells. Especially as it takes ages to even get a buy quote. Nt nt nt every time I tried this week, you can lead a horse to water as they say. Gla ------ Mcrudden23 Dec '19 - 12:15 - 43 of 652 0 0 0 Spot on Dave anyone selling this morning was chasing a rainbow elsewhere, mms have no stock at this level like you said. Solid company big prospects just hold for 5 ------ Mcrudden3 Jan '20 - 16:14 - 54 of 652 0 0 0 So much value in this share anything at these prices is worth multiples. Just got to hold it would seem. ----- yUp | andymunchkin | |
31/8/2023 14:58 | Whatever his real name, this avatar dave is a feral animal, most probably his entire clan has been feral animals. Churchill would have castrated these feral animals. | texas ranger | |
31/8/2023 12:51 | What he said to me does not bother me. I simply said he was just same as those he was calling out on for being pumpers and dumpers. | optmist | |
31/8/2023 09:40 | 150k for me - Lets see where this goes - | tomboyb |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions